Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Prostate Cancer

  Free Subscription


Articles published in Am J Clin Oncol

Retrieve available abstracts of 13 articles:
HTML format



Single Articles


    October 2024
  1. OHAEGBULAM KC, Post CM, Farris PE, Garzotto M, et al
    Safety and Efficacy of Neoadjuvant Docetaxel and Radiotherapy in Localized High-Risk Prostate Cancer: Results From a Prospective Pilot Study.
    Am J Clin Oncol. 2024 Oct 30. doi: 10.1097/COC.0000000000001151.
    PubMed     Abstract available


    September 2024
  2. RITTER AR, Prasad RN, Jhawar SR, Bazan JG, et al
    Hypofractionated Radiation Therapy: A Cross-sectional Survey Study of US Radiation Oncologists.
    Am J Clin Oncol. 2024;47:434-438.
    PubMed     Abstract available


    August 2024
  3. MELLGARD G, Saffran N, Chakrani Z, McCroskery S, et al
    Performance Status and End-of-Life Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Androgen Receptor Targeted Therapy.
    Am J Clin Oncol. 2024 Aug 1. doi: 10.1097/COC.0000000000001115.
    PubMed     Abstract available


    July 2024
  4. LEHRER S, Rheinstein PH
    Salbutamol, a Short Acting Beta-2 Agonist, Reduces Risk and Improves Prognosis of Prostate Cancer.
    Am J Clin Oncol. 2024 Jul 8. doi: 10.1097/COC.0000000000001134.
    PubMed     Abstract available


    February 2024
  5. CHAKRANI Z, Mellgard G, Saffran N, McCroskery S, et al
    Risk Factors for Early Treatment Discontinuation Due to Toxicity Among Patients With Metastatic Castration-resistant Prostate Cancer Receiving Androgen Receptor-targeted Therapy.
    Am J Clin Oncol. 2024 Feb 12. doi: 10.1097/COC.0000000000001087.
    PubMed     Abstract available


    January 2024
  6. JANOPAUL-NAYLOR JR, Koo A, Qian DC, McCall NS, et al
    Physician Assessment of ChatGPT and Bing Answers to American Cancer Society's Questions to Ask About Your Cancer.
    Am J Clin Oncol. 2024;47:17-21.
    PubMed     Abstract available


    May 2023
  7. CAO Z, Yao J, He Y, Lou D, et al
    Association Between Statin Exposure and Incidence and Prognosis of Prostate Cancer: A Meta-analysis Based on Observational Studies.
    Am J Clin Oncol. 2023 May 5. doi: 10.1097/COC.0000000000001012.
    PubMed     Abstract available


    June 2022
  8. BITTNER NHJ, Cox BW, Davis B, King M, et al
    ACR-ABS-ASTRO Practice Parameter for Transperineal Permanent Brachytherapy of Prostate Cancer.
    Am J Clin Oncol. 2022;45:249-257.
    PubMed     Abstract available


    May 2022
  9. POST CM, Kahn JM, Turina CB, Beer TM, et al
    Short-term ADT and Dose-escalated IMRT in Patients With Intermediate-risk Prostate Cancer: Benefit or Caution?
    Am J Clin Oncol. 2022;45:190-195.
    PubMed     Abstract available


    January 2022
  10. ROVIELLO G, Nardone V, Bonetta A, Correale P, et al
    Effects of Whole Pelvic Radiotherapy on the Distribution of Lymphocyte Subpopulations in Prostate Cancer Patients.
    Am J Clin Oncol. 2022 Jan 26. pii: 00000421-900000000-98506.
    PubMed     Abstract available


    October 2021
  11. VIANI GA, Gouveia AG, Jacinto AA, Moraes FY, et al
    Stereotactic Body Radiotherapy for Prostate Cancer: Where, When, and Who? A Bibliometric Analysis.
    Am J Clin Oncol. 2021 Oct 6. pii: 00000421-900000000-98529.
    PubMed     Abstract available


    June 2021
  12. MERRICK GS, Galbreath R, Fiano R, Scholl W, et al
    The Impact of Body Mass Index on Freedom From Therapeutic Intervention and Quality of Life in Active Surveillance Prostate Cancer Patients.
    Am J Clin Oncol. 2021 Jun 7. pii: 00000421-900000000-98553.
    PubMed     Abstract available


    May 2021
  13. SOLIMAN L, De Souza A, Srinivasan P, Danish M, et al
    The Role of BCL-2 Proteins in the Development of Castration-resistant Prostate Cancer and Emerging Therapeutic Strategies.
    Am J Clin Oncol. 2021 May 17. pii: 00000421-900000000-98561.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.